Literature DB >> 20221334

A formalized teaching, practice, and research partnership with the Veterans Affairs North Texas Health Care System: a model for advancing academic partnerships.

Ronald G Hall1, Cynthia Foslein-Nash, Dilpreet K Singh, Robert A Zeiss, Karen M Sanders, Roland Patry, Richard Leff.   

Abstract

In 1999, the Texas Tech University Health Sciences Center School of Pharmacy expanded its Dallas/Fort Worth presence by creating a regional campus for pharmacy students in their third and fourth years (P3 and P4 years) of the program. This expansion was driven by the need for additional practice sites. The VANTHCS was an obvious choice for the school due to the similarity of missions for clinical practice, education, and research. The VANTHCS and pharmacy school renovated a 4,000 square foot building, which includes classrooms, conference rooms, a student lounge, and faculty offices (expanded to 8,000 square feet in 2003). To date, the school has invested $1 million in the building. From a practice perspective, VANTHCS purchases faculty professional services from the school to augment its clinical specialist staff. These professional practice contracts provide VANTHCS with 12 additional clinical pharmacy specialists serving 50% of their time in multiple specialty areas. The collaboration has also allowed for expansion of clinical teaching, benefitting both institutions. In addition to the pharmacy student interns on P3 and P4 practice experiences, the collaboration allows for 8 to 10 postgraduate pharmacy residents to train with VANTHCS clinical specialists and school faculty members each year. The VANTHCS/pharmacy school collaboration has clearly enhanced the ability of both institutions to exceed their teaching, research, and practice goals in a cost-effective manner.

Keywords:  partnership; practice experiences; veterans affairs health system

Mesh:

Year:  2009        PMID: 20221334      PMCID: PMC2828302          DOI: 10.5688/aj7308141

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


  15 in total

1.  Attainment of cholesterol guidelines in patients at high risk for coronary heart disease.

Authors:  Morkisha D Dobard; Sara D Brouse; Manisha J Shah
Journal:  Am J Health Syst Pharm       Date:  2006-02-01       Impact factor: 2.637

2.  Addressing the shortage of pharmacy faculty and clinicians: the impact of demographic changes.

Authors:  Roland A Patry; Lea S Eiland
Journal:  Am J Health Syst Pharm       Date:  2007-04-01       Impact factor: 2.637

3.  A strategy to develop advanced pharmacy practice experiences.

Authors:  Christopher J Turner; Sam Ellis; Joel Giles; Carrie Maffeo; Laura Hansen; Joseph J Saseen; Heather Ulrich; Connie Valdez; Ralph Altiere; Jacquelyn Bainbridge; Robert Page; Charles Sintek; Sheryl Vondracek; Emily Zadvorny; Douglas Fish
Journal:  Am J Pharm Educ       Date:  2007-06-15       Impact factor: 2.047

4.  Use of i.v. immune globulin and occurrence of associated acute renal failure and thrombosis.

Authors:  Sachin Shah; Marne Vervan
Journal:  Am J Health Syst Pharm       Date:  2005-04-01       Impact factor: 2.637

5.  Evaluation of clinical pharmacy services in a hematology/oncology outpatient setting.

Authors:  Sachin Shah; Jonathan Dowell; Shane Greene
Journal:  Ann Pharmacother       Date:  2006-08-01       Impact factor: 3.154

6.  A retrospective study of the lipid-lowering efficacy and safety of ezetimibe added to hydroxy methylglutaryl coenzyme A reductase therapy in HIV-infected patients with hyperlipidemia.

Authors:  Lisa M Chastain; Amy M Bain; Krystal L Edwards; Roger Bedimo; Anthony J Busti
Journal:  J Clin Lipidol       Date:  2007-10-18       Impact factor: 4.766

7.  A randomized trial assessing the utility of a test-dose program with taxanes.

Authors:  B L Stanford; S R Shah; E E Ballard; C A Jumper; I Rabinowitz; J E Dowell; W C Hunt; J A Krieger
Journal:  Curr Med Res Opin       Date:  2005-10       Impact factor: 2.580

8.  Safety and efficacy of simvastatin for the treatment of dyslipidemia in human immunodeficiency virus-infected patients receiving efavirenz-based highly active antiretroviral therapy.

Authors:  Anita P Rahman; Susan A Eaton; Sean T Nguyen; Amy M Bain; Kenna D Payne; Roger Bedimo; Anthony J Busti
Journal:  Pharmacotherapy       Date:  2008-07       Impact factor: 4.705

9.  Multicenter evaluation of vancomycin dosing: emphasis on obesity.

Authors:  Ronald G Hall; Kenna D Payne; Amy M Bain; Anita P Rahman; Sean T Nguyen; Susan A Eaton; Anthony J Busti; Stephen L Vu; Roger Bedimo
Journal:  Am J Med       Date:  2008-06       Impact factor: 4.965

10.  Improvement in insulin sensitivity and dyslipidemia in protease inhibitor-treated adult male patients after switch to atazanavir/ritonavir.

Authors:  Anthony J Busti; Roger Bedimo; David M Margolis; Dana S Hardin
Journal:  J Investig Med       Date:  2008-02       Impact factor: 2.895

View more
  3 in total

1.  Reexamining the Academic Partnerships with Federal Pharmacy: 2018-19 Argus Commission Report.

Authors:  Peggy Piascik; Cynthia J Boyle; Patricia Chase; Joseph T DiPiro; Steven T Scott; Lucinda L Maine
Journal:  Am J Pharm Educ       Date:  2019-12       Impact factor: 2.047

2.  Unique collaboration between a private college of pharmacy and a private academic health system.

Authors:  Nicole Metzger; Christopher Paciullo; Melissa Chesson; Michael W Jann; Janice Glascock; Amir Emamifar; Hewitt W Matthews
Journal:  Hosp Pharm       Date:  2014-07

3.  Evaluation of an Interprofessional Academic-Practice Partnership in End of Life Care.

Authors:  Katie F Leslie; M Kate Probst; Taylor L Hawkins
Journal:  Innov Pharm       Date:  2021-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.